Davidson Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.11M Buy
9,653
+386
+4% +$178K 0.82% 34
2026
Q1
$4.45M Buy
9,267
+274
+3% +$140K 0.81% 41
2025
Q4
$5.05M Sell
8,993
-197
-2% -$112K 1.09% 13
2025
Q3
$4.73M Sell
9,190
-284
-3% -$124K 1.06% 10
2025
Q2
$2.97M Buy
9,474
+320
+3% +$96.1K 0.71% 47
2025
Q1
$2.79M Sell
9,154
-518
-5% -$174K 0.76% 36
2024
Q4
$3.21M Buy
9,672
+1,279
+15% +$434K 0.85% 36
2024
Q3
$2.8M Buy
8,393
+629
+8% +$239K 0.81% 40
2024
Q2
$3.2M Buy
7,764
+340
+5% +$135K 0.99% 26
2024
Q1
$3M Sell
7,424
-608
-8% -$214K 0.97% 17
2023
Q4
$2.46M Buy
+8,032
New +$2.17M 0.89% 27

Other funds holding MEDP

Davidson Capital Management's MEDP Position: Q2 2026 in Review

Davidson Capital Management increased its Medpace (MEDP) stake by 4.2% in Q2 2026, buying an estimated $178K and bringing the position to 9,653 shares worth $5.11M. The position accounts for 0.82% of the portfolio, ranked #34.

Davidson Capital Management first reported a position in MEDP in Q4 2023 and has held it in 11 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Davidson Capital Management held 9,653 shares of Medpace worth $5.11M as of Q2 2026.
  • Davidson Capital Management bought 386 Medpace shares in Q2 2026, an estimated $178K.
  • Medpace made up 0.82% of Davidson Capital Management's portfolio in Q2 2026, its #34 holding.
  • Davidson Capital Management first reported a position in Medpace in Q4 2023 and has held it in 11 quarters since.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Davidson Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.